SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $108.1 million in its fourth quarter.
The Salt Lake City-based company said it had a loss of 21 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.
The biotechnology company posted revenue of $35.5 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $25.5 million.
For the year, the company reported a loss of $644.8 million, or $1.44 per share. Revenue was reported as $74.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
